Axsome Therapeutics, Inc.
Use of reboxetine to treat narcolepsy

Last updated:

Abstract:

Described herein are methods of treating narcolepsy with cataplexy, comprising administering reboxetine to a human being in need thereof. Reboxetine may also be used in the manufacture of a medicament for the treatment of narcolepsy with cataplexy. Also disclosed herein are kits comprising a pharmaceutical composition comprising reboxetine and instructions to use the pharmaceutical composition to treat narcolepsy with cataplexy in a human being.

Status:
Grant
Type:

Utility

Filling date:

11 Jan 2020

Issue date:

7 Jun 2022